Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis
Open accessThe DOI matches its Crossref record; 241 of the 245 references it cites were found in a registry or an index.
Abstract
In cancer cells, a vital cellular process during metastasis is the transformation of epithelial cells towards motile mesenchymal cells called the epithelial to mesenchymal transition (EMT). The cytoskeleton is an active network of three intracellular filaments: actin cytoskeleton, microtubules, and intermediate filaments. These filaments play a central role in the structural design and cell behavior and are necessary for EMT. During EMT, epithelial cells undergo a cellular transformation as manifested by cell elongation, migration, and invasion, coordinated by actin cytoskeleton reorganization. The actin cytoskeleton is an extremely dynamic structure, controlled by a balance of assembly and disassembly of actin filaments. Actin-binding proteins regulate the process of actin polymerization and depolymerization. Microtubule reorganization also plays an important role in cell migration and polarization. Intermediate filaments are rearranged, switching to a vimentin-rich network, and this protein is used as a marker for a mesenchymal cell. Hence, targeting EMT by regulating the activities of their key components may be a potential solution to metastasis. This review summarizes the research done on the physiological functions of the cytoskeleton, its role in the EMT process, and its effect on multidrug-resistant (MDR) cancer cells-highlight some future perspectives in cancer therapy by targeting cytoskeleton.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A schematic diagram illustrating the resistance mechanisms associated with anti-microtubule drugs. These drugs cross the lipid bilayer of the cell membrane and then bind themselves to β-tubulin to alter the microtubule dynamics, causing mitotic arrest and consequent apoptosis. Drugs can be effluxed before reaching the cellular target with the aid of functional drug transport protein. Disruption in the tubulin/microtubule system can avert anti-microtubule drugs from disrupting the microtubules and leading to drug resistance. Before drug binding occurs, signaling and anti-apoptotic factors may also contribute to drug resistance. MF: microfilaments, Mt: microtubules. [212]. The figure was created with BioRender.com (Accessed on 1 February 2021) and was exported under a paid subscription.](https://figures.cochat.ai/paper-figures/c0e6c310a36f4170b5ceec5f7c0b9936/cytoskeletal-dynamics-in-epithelial-mesenchymal-transition-insights-into-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A critical step in the progression of ovarian cancer metastasis is the epithelial-to-mesenchymal transition (EMT), which is characterized by the loss of E-cadherin, cytoskeletal remodeling and changes in proliferation, motility and apoptosis (Ahmed et al., 2007; Moreno-Bueno et al., 2009; Datta et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Datta et al., 2021
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lahat, G., Zhu, Q.-S., Huang, K.-L., Wang, S., Bolshakov, S., Liu, J., Torres, K., Langley, R. R., Lazar, A. J., Hung, M. C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010105 · Cited by 213
RetractedThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091 · cited 19×
“Epithelial cells are held together by tight junctions (TJs), adherens junctions (AJs), and desmosomes and are also connected to the extracellular matrix (ECM) through integrins [9].”
BackgroundInfluentialMicrotubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000 · cited 1×
“When cells are exiting mitosis, the reverse process, where mitotic spindles resolve and MT network reforms, would result in two functional daughter cells [49,51].”
BackgroundNew insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876 · cited 2×
“On the other hand, N-cadherin, fibronectin, vitronectin, and MMPs are transcriptionally upregulated by these three transcription factors, contributing to the mesenchymal phenotypes of the cells [4,10,13,14].”
BackgroundThe Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
CNS stem cells express a new class of intermediate filament protein
Lendahl, U., Zimmerman, L. B., & McKay, R. D. G. (1990) · Cell · doi:10.1016/0092-8674(90)90662-x · Cited by 3,151
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Guidelines and definitions for research on epithelial-mesenchymal transition
Yang, J., Antin, P., Berx, G., Blanpain, C., Brabletz, T., Bronner, M., Campbell, K., Cano, A., Casanova, J., Christofori, G., et al. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0237-9 · Cited by 2,226 · cited 1×
“EMT is a reversible process—EMT followed by a MET is crucial for cancer metastasis [15].”
BackgroundMolecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,080
Cited by
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
Self-citationSTAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Sadrkhanloo, M., Entezari, M., Orouei, S., Ghollasi, M., fathi, N., Rezaei, S., Hejazi, E. S., Kakavand, A., Saebfar, H., Hashemi, M., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106311 · Cited by 185
Paskeh, M. D. A., Ghadyani, F., Hashemi, M., Abbaspour, A., Zabolian, A., Javanshir, S., Razzazan, M., Mirzaei, S., Entezari, M., Goharrizi, M. A. S. B., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106553 · Cited by 177
Self-citationHashemi, M., Arani, H. Z., Orouei, S., Fallah, S., Ghorbani, A., Khaledabadi, M., Kakavand, A., Tavakolpournegari, A., Saebfar, H., Heidari, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113774 · Cited by 166
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression
Deng, S., Leong, H. C., Datta, A., Gopal, V., Kumar, A. P., & Yap, C. T. (2022) · Cancers · doi:10.3390/cancers14071652 · Cited by 135
“During the EMT process, the cytoskeleton is restructured under a coordinated regulation of ABPs, MTBPs, and regulators of IFs, to weaken cell-cell attachment and strengthen cell-matrix adhesions that transform cancer cells from the stationary epithelial type into migratory mesenchymal type [47,48].”
BackgroundSelf-citation
Metadata
- Authors
- Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., Kumar, A. P., & Yap, C. T.
- Affiliations
- National University of Singapore (SG)
- Corresponding author
- Kumar, Alan Prem
- Yap, Celestial T.
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-04-14
- Volume
- 13
- Issue
- 8
- Pages
- 1882
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8070945
- OpenAlex
- W3156599094
- Cited by
- 184
- References
- 245
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 34 · 2023: 33 · 2022: 30 · 2021: 12
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Medical Research Council (r-185-000-353-213)
- Ministry of Education - Singapore (MOE-T2EP30120-0016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- epithelial-mesenchymal transition, cytoskeleton, actin cytoskeleton, microtubules, intermediate filaments, vimentin, metastasis, cell migration, cell invasion, actin-binding proteins, multidrug resistance, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis. https://app.cochat.ai/papers/10.3390/cancers13081882
- The paper
- Datta, A., Deng, S., Gopal, V., Yap, K. C.-H., Halim, C. E., Lye, M. L., Ong, M. S., Tan, T. Z., Sethi, G., Hooi, S. C., Kumar, A. P., & Yap, C. T. (2021). Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights into Therapeutic Targets for Cancer Metastasis. Cancers. https://doi.org/10.3390/cancers13081882
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.